TB-500
Also known as: Thymosin Beta-4 Fragment
Primary recreational use: Tissue repair and recovery
What is TB-500?
TB-500 is a synthetic peptide derived from the active region of Thymosin Beta-4, specifically designed to promote tissue repair and regeneration. Initially developed for veterinary use in horses, it has gained traction in human applications for its wound healing and anti-inflammatory properties. While it is not FDA-approved for medical use, it is under investigation in clinical trials for wound healing. Concerns exist regarding its theoretical cancer-promoting potential due to angiogenesis.
Primary Benefits
Accelerated wound healing. Reduced inflammation. Enhanced tissue repair.
How It Works
TB-500 works by binding to and sequestering actin, facilitating cell migration and tissue repair. It promotes angiogenesis, reduces inflammation, and activates stem cell differentiation, predominantly through its role in actin regulation.
Safety Tips
Precautions reported in community discussions and literature. This is not a complete list.
- 1.DON'T use TB-500 if you have a history of cancer or are currently undergoing cancer treatment.
- 2.NEVER inject TB-500 without following sterile techniques to avoid infections.
- 3.AVOID using TB-500 without consulting a healthcare provider if you have immune system disorders.
- 4.DON'T exceed recommended dosages hoping to expedite results; this increases risk of adverse effects.
- 5.NEVER store TB-500 without refrigeration once it is reconstituted.
Use Contexts
Different purposes have different protocols, dosing, and considerations
Wound healing
moderate evidenceExperimental users inject TB-500 to enhance systemic tissue repair, focusing on accelerating the healing of dermal and muscular injuries.
Evidence: Various studies report TB-500's potential in accelerating wound healing, with ongoing clinical trials for this purpose.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Flexible, best in morning or evening
Notes: Following loading phase, reduce frequency for maintenance; stack with BPC-157 for optimal results
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| General tissue repair | 2-3mg | 2x weekly | Subcutaneous |
| Serious injury recovery | 4-5mg | 3x weekly | Subcutaneous near injury site |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Serious / Rare
- Theoretical cancer cell motility risk
Injection-Specific Warnings
- Use sterile injection technique to prevent infection
- Avoid during active cancer treatment
Storage
Harm Reduction Information
Quality Concerns
- Purity may be compromised in non-research settings.
- Risk of contamination during reconstitution or injection
Safety Tips
- Practice sterile injection techniques at all times.
- Use bacteriostatic water for reconstitution.
- Start with lower doses to gauge response and side effects.
Warning Signs to Stop
- Unusual lumps or changes in moles
- Severe allergic reactions like hives or difficulty breathing
Seek Medical Help Immediately If
- Severe injection site reactions
- Sudden, severe headaches
- Signs of an allergic reaction
Frequently Asked Questions
Common questions about TB-500
How long until I see effects?
With TB-500, users typically start noticing reduced inflammation and improved tissue sensation within the first 1-2 weeks of use.
What time of day should I take it?
TB-500 has a flexible timing schedule due to its long half-life, so administration time can be adjusted to your convenience, but consistency is key.
How can I minimize side effects?
To minimize side effects with TB-500, adhere strictly to sterile injection practices and recommended dosing guidelines.
Does tolerance develop?
There is no strong evidence to suggest that users develop tolerance to TB-500. However, cycling is recommended to ensure effectiveness.
How should I store it?
Store TB-500 in a refrigerator between 2-6°C after reconstitution and use within 28 days.
Do I need to cycle it?
Yes, it's advisable to cycle TB-500 to avoid potential issues and maintain its effectiveness.
Reported Combinations
Compounds reported to be used alongside TB-500 in community discussions
BPC-157
Enhances healing when combined with TB-500; promotes better tissue regeneration.
CJC-1295
Potential synergistic effects in tissue repair and muscle growth due to increased IGF-1 release.
IGF-1
May enhance TB-500's regenerative and performance-enhancing effects.
Reported Interactions
Interactions reported in literature and community discussions.
May increase bleeding risk; use caution.
No known interactions, generally safe.
Monitor blood pressure closely; potential alteration in effects.
Reconstitution Calculator
100 units = 1 mL
Safety Tips
- Always consult a licensed medical professional for dosing and reconstitution instructions.
- Always double check your units. Mixing up mg and mcg can be very dangerous.
- Make sure to select your syringe type. U-100 and U-50 syringes have different units.
- Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.
This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.
Legal Status by Region
Regulatory status varies by country
USA
considered research chemical
UK
considered research chemical
EU
considered research chemical
Australia
considered research chemical
Canada
considered research chemical
Explore More Research
Browse our database of peptide research information compiled from published literature and community sources.
Citations
Last updated: October 3, 2023